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ABSTRACT 
This EFSA Scientific Report reviews and discusses the provisional results of a study (EURL/Cypriot study) on 
genetic resistance to Classical scrapie in goats in Cyprus. It is concluded that the provisional results obtained in 
the study further support the lower susceptibility to Classical scrapie in goats carrying the D146 and S146 alleles 
compared to wild type (N146N) goats. The results from intracerebral challenge are not compatible with a level 
of resistance as high as the one observed in sheep carrying the ARR allele or in goats carrying the K222 allele. 
Final results from the oral challenge will be crucial in determining the level of resistance associated with the 
D146  and  S146  alleles.  Furthermore,  it  is  concluded  that  the  provisional  results  obtained  in  the  study  are 
compatible with the possibility to use the D146 and S146 alleles to build a genetic strategy to control and 
eradicate Classical scrapie in goats in Cyprus. However, the success of such a strategy will be determined by the 
level of resistance associated with the D146 and S146 alleles against infection with all the different TSE agents 
proved to be circulating in Cyprus, which at this stage of the EURL/Cypriot study remains to be definitively 
assessed. In addition, as compared to the results of the model developed in the study, it is concluded that the 
efficiency of the implementation in the field of a breeding strategy selecting for the D146 and S146 alleles may 
be lower due to potential practical constraints related to the management of genetic diversity, to the selection for 
production  and  health  traits  and  to  the  need  of  moving  animals  for  breeding  purposes  in  Cyprus. 
Recommendations on aspects that may be considered when completing the study are formulated. 
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KEY WORDS 
TSE, Classical scrapie, goat, genetic resistance, breeding programme, Cyprus. 
 
                                                       
1  On request from the European Commission, Question No EFSA-Q-2012-00669, approved on 21 November 2012. 
2  Correspondence: biohaz@efsa.europa.eu  
3  Acknowledgement: EFSA wishes to thank the members of the Working Group on Genetic resistance to scrapie in goats in 
Cyprus: Pier Luigi Acutis, Olivier Andreoletti, Jean-Michel Elsen and Emmanuel Vanopdenbosch for the preparatory work 
on  this  scientific  output  and  the  hearing  experts:  Mike  Dawson,  Soteria  Georgiadou,  Angel  Ortiz-Pelaez,  Penelope 
Papasavva Stylianou, Marion Simmons and Otto Windl for the support provided to this scientific output. 
 Genetic resistance to Classical scrapie in goats in Cyprus 
 
EFSA Journal 2012;10(11):2972  2 
SUMMARY 
Following  a  request  from  the  European  Commission,  EFSA  was  asked  to  provide  scientific  and 
technical assistance on the provisional results of a study on genetic resistance to Classical scrapie in 
goats  in  Cyprus.  The  study  was  performed  by  the  European  Union  Reference  Laboratory  for 
Transmissible  Spongiform  Encephalopathies  (TSE  EURL)  and  the  Cypriot  Veterinary  Services 
(CVS). In 2006/2007 a pilot project on this topic was undertaken in Cyprus. In 2009 EFSA was asked 
by the European Commission to evaluate the results from the pilot project and, later, a draft protocol 
for additional studies. A final protocol for new studies to be carried out in Cyprus was subsequently 
agreed by the European Commission, the TSE EURL and the CVS. Implementation of the protocol 
started at the end of 2009 (EURL/Cypriot study). 
This EFSA Scientific Report reviews and discusses the provisional results of the EURL/Cypriot study 
as concerns the four research areas implemented: i) effect of D146 and S146 PRNP alleles on the 
individual  susceptibility  to  Classical  scrapie  infection;  ii)  TSE  agent  diversity  and 
resistance/susceptibility associated with the D146 and S146 alleles; iii) effect of D146 and S146 PRNP 
alleles on Classical scrapie pathogenesis; and iv) capacity for selection and diffusion of the PRNP 
allele in the Cypriot goat population. 
It is concluded that the provisional results obtained in the study further support the lower susceptibility 
to Classical scrapie in goats carrying the D146 and S146 alleles compared to wild type (N146N) goats. 
The results from intracerebral challenge are not compatible with a level of resistance as high as the 
one observed in sheep carrying the ARR allele or in goats carrying the K222 allele. Final results from 
the oral challenge will be crucial in determining the level of resistance associated with the D146 and 
S146 alleles. 
Furthermore, it is concluded that the provisional results obtained in the study are compatible with the 
possibility  to  use  the  D146  and  S146  alleles  to  build  a  genetic  strategy  to  control  and  eradicate 
Classical scrapie in goats in Cyprus. However, the success of such a strategy will be determined by the 
level of resistance associated with the D146 and S146 alleles against infection with all the different 
TSE agents proved to be circulating in Cyprus, which at this stage of the EURL/Cypriot study remains 
to be definitively assessed. In addition, as compared to the results of the model developed in the study, 
it is concluded that the efficiency of the implementation in the field of a breeding strategy selecting for 
the  D146  and  S146  alleles  may  be  lower  due  to  potential  practical  constraints  related  to  the 
management of genetic diversity, to the selection for production and health traits and to the need of 
moving animals for breeding purposes in Cyprus. 
The  Scientific  Report  formulates  recommendations  on  aspects  that  may  be  considered  when 
completing the study. In particular, approaches are suggested for characterising TSE isolates from 
Cypriot goats and estimating the potential level of resistance towards them associated to the D146 and 
S146  alleles.  Suggestions  are  made  about  possible issues to  be  considered in  the  analysis  of  the 
capacity for selection and diffusion of the alleles of interest. Finally, it is indicated that introgression 
of the K222 allele into the Cypriot goat Damascus breed could be considered as a possible alternative 
to selection for the D146 and S146 alleles in case this solution was not suitable. Genetic resistance to Classical scrapie in goats in Cyprus 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
On 24 March 2009 and following a request from the Commission, EFSA published a scientific opinion 
on genetic resistance to scrapie in goats in consideration of a pilot project study carried out in Cyprus
4. 
The report of the Cypriot pilot study presented a case control study in Cypriot goat herds aiming at the 
identification of the effect of PRNP polymorphisms on TSE susceptibility. According to the author of 
the report, the results obtained would indicate a higher resistance against clinical disease in goats 
bearing the H154, D146 or S146 PRNP polymorphism than in goats bearing R154 or N146. 
The BIOHAZ Panel was requested to assess the scientific validity of the study and to indicate to what 
extent, based on this study, genetic breeding can be used as a control program for Classical scrapie in 
goats in Cyprus. 
The  BIOHAZ  Panel  concluded  that  the  study  conducted  in  Cyprus  brings  additional  proof  of  a 
potential lower  susceptibility  to  Classical  scrapie in  goats in  H154,  D146  and  S146  PRNP allele 
carriers  and  can  be  considered  as  encouraging  information  on  the  path  for  identifying  PRNP 
polymorphisms that could be used as part of a genetic strategy to control and eradicate TSE agents in 
goats. However, the BIOHAZ Panel concluded at the same time that the study on its own was an 
insufficient  basis  to  evaluate  accurately  and  reliably  the  efficacy  and  the  potential  adverse 
consequence of the large-scale breeding for H154, D146 and S146 PRNP alleles as a tool to control 
and eradicate Classical scrapie in Cyprus and recommended new investigations in order to assess the 
efficacy of breeding for the PRNP alleles in goat populations in Cyprus. In addition, the operational 
possibility to conduct these alleles selection in the Cypriot goat population and the potential adverse 
effect of such selection on genetic variability in the Cypriot goat breeds should be evaluated. 
Following the publication of this opinion, the Commission tasked the EU Reference Laboratory for 
TSEs (EURL-TSE) to draft a new protocol for additional studies in order to adequately supplement the 
initial findings of the Cypriot pilot study and following the six areas of research as given in the EFSA 
Scientific Opinion. 
EFSA was tasked by the Commission on 4 June 2009 to evaluate this amended protocol and published 
a statement on 24 July 2009
5. The BIOHAZ Panel concluded that the protocol is an extension and an 
improvement of the earlier pilot project. The BIOHAZ Panel made a series of detailed conclusions and 
recommendations for further development of the EURL protocol. 
The EURL-TSE and the Cypriot veterinary services launched the implementation of the protocol at the 
end of 2009. The EURL-TSE produced in May 2012 the 5
th progress report of the study. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
EFSA is requested to provide scientific and technical assistance to the Commission on the following 
questions, based on the 5
th progress report published by the EURL-TSE in May 2012: 
1.  Are  the  provisional  results  of  the  study  supportive  of  a  significantly  lower  susceptibility  to 
Classical scrapie in goats carrying the D146 and S146 alleles? 
2.  Are  the  provisional  results  of  the  study  consistent  with  the  possibility  to  use  this  PRNP 
polymorphism in the future to build a genetic strategy to control and eradicate Classical scrapie in 
goats in Cyprus? 
 
                                                       
4  doi:10.2903/j.efsa.2009.995. Genetic TSE resistance in goats. 
5  doi:10.2903/j.efsa.2009.1203. Statement on a protocol for additional data collection based on the EFSA 
recommendations about resistance to scrapie in goats in Cyprus. Genetic resistance to Classical scrapie in goats in Cyprus 
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Clarification of the Terms of Reference 
After discussion with the requestor of the mandate (European Commission), the Terms of Reference 
were further clarified and it was agreed to delete the word “significantly” from the first Term of 
Reference, which would read as follows: “Are the provisional results of the study supportive of a 
lower susceptibility to Classical scrapie in goats carrying the D146 and S146 alleles?”. 
CONTEXT OF THE SCIENTIFIC OUTPUT 
As introduced in the Background section above, after the evaluation by EFSA (EFSA, 2009) of the 
results of a study conducted in Cyprus to investigate the association of polymorphisms of the PRNP 
gene at codons 146 and 154 in goats with susceptibility/resistance to Classical scrapie in Cyprus, the 
protocol for a new study was submitted by the European Commission to EFSA, with the request to 
indicate whether the protocol was appropriate to adequately supplement the initial findings of the 
Cypriot study and was addressing the recommendations of the previous EFSA Opinion (EFSA, 2009). 
Following  to  this  request,  EFSA  published  a  Statement  (EFSA  Panel  on  Biological  Hazards 
(BIOHAZ), 2009), concluding that the protocol was an improvement of the earlier pilot project, and 
providing  a  series  of  conclusions  and  recommendations  for  its  further  development.  Detailed 
comments were provided for the six different research areas originally recommended for research 
(EFSA, 2009) and developed by the protocol. 
In its overall conclusions, the BIOHAZ Panel (2009) indicated that the low frequencies of the PRNP 
alleles of interest in the population compromise the statistical power of the proposed protocol. Since 
the potential diversity of TSE agents in Cypriot goats could not be foreseen, the systematic screening 
of all samples available by high throughput biochemical test was advised rather than the proposed 
reduced panel of isolates. It was further indicated that in vitro conversion assays were available and 
could be used to document potential resistance associated to the D146 and S146 PRNP alleles, and 
that standardised bioassays of TSE isolates of interest, as used by the Strain Typing Expert Group 
(STEG), were necessary to document the biodiversity of TSE strains in goats in Cyprus. Considering 
the limited frequencies of the PRNP alleles of interest and the assumed prevalence of Classical scrapie 
in infected herds, it was concluded that the proposed experiments were unlikely to document the 
distribution of PrP
Sc in homozygous goats but could document, within some limits, the distribution of 
PrP
Sc  in  heterozygous  goats.  It  was  also indicated  that the  modelling  approach  on feasibility  and 
duration of selection for resistant alleles was subject to the availability of input data. Finally, it was 
concluded that the proposed protocol could not substitute the experiments advised in the earlier EFSA 
Opinion EFSA (2009) on cohort follow up and experimental inoculation, which remained crucial for 
definitive assessment of D146 and S146 PRNP alleles’ resistance. 
Following to the publication of the EFSA Statement (EFSA Panel on Biological Hazards (BIOHAZ), 
2009), a final protocol for the studies to be carried out in Cyprus was agreed in October 2009 by the 
European Commission, the European Union Reference Laboratory for TSE (TSE EURL) and the 
Cyprus Veterinary Services. Implementation of the protocol started at the end of 2009 (EURL/Cypriot 
study). 
Since then additional scientific information has become available in relation to genetic resistance to 
Classical scrapie in goats. In particular, some studies support a potential high level of resistance for 
goats  carrying  the  S146  and  K222  alleles  (Acutis  et  al.,  2012;  White  et  al.,  2012).  Additional 
experiments are ongoing in the framework of European research projects (European goatBSE project, 
EMIDA goat TSE free project), which are providing useful information in relation to breeding for TSE 
resistance in goats. 
It should be noted that the present report addresses only Classical scrapie and no conclusions can be 
drawn  with  respect  to  other  TSEs  in  goats.  Practical  definitions  of  the  different  TSEs  in  small 
ruminants can be found in a previous EFSA Opinion (2005). Genetic resistance to Classical scrapie in goats in Cyprus 
 
EFSA Journal 2012;10(11):2972  6 
ASSESSMENT 
1.  EURL/Cypriot study, Research area 1 
1.1.  Brief overview of the study 
The objective of this research area was to study the effect of D146 and S146 alleles on individual 
susceptibility to Classical scrapie infection. The study was composed of different parts: 
  Intracerebral (i.c.) challenge of goats homozygous and heterozygous for the alleles of interest. 
Thirty-seven  goats were included in the study:  eight animals for each of the D146D, S146S, 
N146S  and  N146D  putative  resistant  genotypes,  and  five  animals  of  the  N146N  putative 
susceptible genotype (wild type). All recipient and donor animals in the inoculation experiments 
were homozygous R at codon 154. The inoculum used for the experiment consisted of a pool of 
brain material from 12 field cases of scrapie in N146N goats from Cyprus. All the brains were 
tested for abnormal PrP presence by Western blot, and BSE was excluded on the basis of PrP
Sc 
biochemical properties. Recipient animals were killed as soon as they reached a clinical disease 
endpoint and PrP
Sc distribution and amount were determined in their nervous, lymphoid, muscular 
tissues and other tissues by ELISA and immunohistochemistry. 
Four of the animals challenged died from intercurrent diseases, but all of them tested negative for 
TSE. All the other animals were culled following clinical disease, and tested positive. The mean 
incubation times observed in the different genotype groups are reported in Table 1. 
While all N146N animals were central nervous system (CNS) and lymphoreticular system (LRS) 
positive, the heterozygous and homozygous animals for both 146D and 146S allele remained LRS 
negative. 
Table 1:    Mean incubation times of intracerebrally challenged goats according to their genotype. 
Genotype  Mean incubation time (days) 
D146D  489 
S146S  556 
N146S  564 
N146D  425 
N146N  427 
 
  Oral challenge of goats homozygous and heterozygous for the alleles of interest. 
For this experiment 125 goats were inoculated orally with the inoculum described above. The age 
of animals at challenge ranged from 2 to 15 months, with about 72% of the animals being below 6 
months of age, and 28% above. Groups of five inoculated animals of different genotypes (D146D, 
S146S, N146S, N146D, N146N) were killed at 6, 12 and 24 months post inoculation (mpi), and 
several tissues tested for PrP
Sc presence by ELISA and immunohistochemistry. The remaining 
animals are currently alive and kept under observation until clinical signs are observed or the 
animals have to be culled for welfare reasons. 
According to the provisional results of the study, positive findings have been so far described only 
in goats carrying the N146N genotype. In particular, 1 out of 5 tested positive at 6 mpi (palatine 
tonsil and retropharyngeal lymph node), 4 out of 5 at 12 mpi (lymphoreticular system, with one of 
them also positive in the brainstem), and 4 out of 4 at 24 mpi (both lymphoreticular and CNS 
system). One additional goat carrying the N146N genotype died at 23 mpi and also tested positive. 
No positive findings were described in animals of the other genotypes under investigation. Genetic resistance to Classical scrapie in goats in Cyprus 
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  Genotyping of the entire Cypriot goat population. 
The aim of the study was to perform the PrP genotyping (codons 146 and 154) of the entire 
Cypriot goat population. 
So far, over 318,000 goats were genotyped. The large majority of animals showed to carry the 
R154R  genotype  (91.5%).  Among  the  R154R  goats,  for  which  more  detailed  information  is 
available,  the  following  frequency  was  reported  for  the  different  genotypes:  71.16%  for  the 
N146N, 12.74% for the N146D, 11.90% for the N146S, 1.52% for the S146D, 1.39% for the 
D146D, and 1.30% for the S146S genotypes. Data show a low frequency of non-N146 goats.  
  Management cull. 
For this experiment animals from scrapie-infected herds were selected according to pre-specified 
criteria (i.e. animals included in the study to be over 6 years of age, homozygous and heterozygous 
for the alleles of interest, originating from herds with confirmed cases of scrapie for at least 6 
years).  The  experiment  is  still  ongoing,  and  so  far  samples  from  423  goats  (obex  and 
retropharyngeal lymph node) from 37 scrapie infected herds were collected and tested by means of 
ELISA and immunohistochemistry. 
Among  the  tested samples,  all the  109  positive  cases  were identified in animals  carrying  the 
N146N genotype (109 over 273 N146N animals tested). No positive case was reported among the 
remaining 150 animals (69 N146S, 72 N146D, 4 D146D, 4 S146D, 1 S146S).  
More details on the provisional results of the study can be found in the EURL/Cypriot 5
th report on 
progress (see Appendix A). 
1.2.  Considerations on the provisional results of the study 
1.2.1.  Intracerebral challenge experiment 
Intracerebral challenge of animals harbouring different genotypes is used to obtain an estimate of the 
ability/efficacy  of  TSE  agents  to  propagate  in  a  given  PrP  substrate.  Lack  of  transmission  in  a 
particular  PrP  variant  compared  to  a  100%  attack  rate  in  wild  type  PrP  qualifies  for  a  low 
susceptibility/strong resistance to infection. Longer incubation periods of the disease in inoculated 
animals without a reduction of the attack rate are also compatible with a lower susceptibility/higher 
resistance to the infection. 
The results obtained by the EURL/Cypriot study do not indicate an association between the tested PrP 
polymorphism and the transmission attack rate. A statistical analysis of the difference in incubation 
period between the different genotype groups remains necessary to assess its significance and the 
potential impact of PrP genotype on the incubation period. 
In previous experiments in Classical scrapie i.c. challenged homozygous ARR sheep (Foster et al., 
2001; Goldmann et al., 1994) and heterozygous K222 goats (Acutis et al., 2012), no clinical signs or 
PrP
Sc accumulation in brain or lymphoid tissue were observed. These results were compatible with 
very high resistance to infection. 
The results obtained by the EURL/Cypriot study after i.c. challenge of S146 and D146 allele carriers 
are not compatible with a level of resistance as high as the one observed in ARR sheep or in K222 
goats. 
The  absence  of  PrP
Sc  accumulation  in  lymphoid  tissue  from  i.c.  challenged  homozygous  and 
heterozygous S146 and D146 animals, as obtained by the EURL/Cypriot study, cannot be considered 
as an indicator of a potential resistance. In heterozygous Q211 goats, PrP
Sc was observed in lymphoid 
tissue after i.c. challenge with a Classical scrapie isolate, whereas hardly any deposit was identified in Genetic resistance to Classical scrapie in goats in Cyprus 
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the lymphoreticular system of the homozygous Q211 challenged animals
6. However, in another study 
(Corbière et al., 2012) both genotypes showed a similar degree of resistance to the infection compared 
to baseline goats (homozygous I142R154R211Q222S240 goats) under natural exposure conditions. 
1.2.2.  Oral challenge experiment 
Oral inoculation of animals is considered as the best proxy for natural contamination with TSE agents 
in ruminants. It provides an estimate of the level of resistance associated to particular PrP alleles to the 
infection with a TSE agent. It encompasses not only the capacity of the agents to replicate in a PrP 
substrate, as assessed in i.c. challenge experiments, but also the ability of the agent to  infect and 
disseminate efficiently in hosts harbouring a particular PrP genotype. Nevertheless, oral experimental 
exposure cannot be considered to perfectly reproduce the natural disease (Tabouret et al., 2010). 
Recent results obtained in sheep of a fully susceptible genotype after oral challenge with Classical 
BSE demonstrated the strong influence of the age of the recipient at inoculation on the efficacy of 
disease  transmission  (Hunter  et  al.,  2012).  A  significant  reduction  in  disease  transmission  was 
observed in animals challenged after weaning. This phenomenon was more marked as the age of the 
animals increased. These results are fully consistent with those reported for naturally scrapie affected 
flocks, where disease is more rarely observed in animals introduced at adult age by comparison to 
animals introduced at younger age (Hourrigan et al., 1979). 
The  provisional  results  obtained  by  the  EURL/Cypriot  study  indicate  that  none  of  the  orally 
challenged homozygous/heterozygous S146 and D146 allele carriers  has so far  developed clinical 
disease or accumulated PrP
Sc in either central nervous system (CNS) or lymphoid tissue. These results 
are in line with those recently reported in orally challenged N146S goats by White et al. (2012). They 
are  potentially  compatible  with  a  low  susceptibility/high  resistance  to  infection  following  oral 
exposure to the pool of Classical scrapie isolates used in the experiment. Alternatively, as reported by 
Gonzalez et al. (2010; 2009) for some animals carrying methionine at codon 142, and observed in the 
EURL/Cypriot study (Research area 3), these observations could be the consequence of an efficient 
infection in the absence of replication in lymphoid tissue before invasion of the CNS and onset of 
clinical signs (which may happen at a later stage). 
Final results from the oral challenge, including long-term observations of the last groups of challenged 
goats, will be crucial in determining the level of resistance associated with the S146 and D146 alleles. 
However, the age at challenge over six months of some of the animals belonging to these groups may 
interfere with the final interpretation of the results. 
1.2.3.  Management cull experiment 
The management cull experiment brought additional data indicating a lower susceptibility to Classical 
scrapie infection in Cypriot goats carrying the S146 and D146 alleles compared to homozygous N146 
goats. Because of the limited frequency of homozygous D146 and S146 and heterozygous S146D 
animals in the population under investigation, this part of the experiment does not provide elements in 
relation to these genotypes. 
The results obtained are fully consistent with those reported in the 2006/2007 pilot project (EFSA, 
2009). A statistical analysis will be needed to compare odds of infection in the different genotype 
groups. 
                                                       
6  Results obtained in the framework of the European goatBSE project (FOOD-CT-2006-36353). Details on the 
results are available upon request to the project coordinator (see www.goatbse.eu). Genetic resistance to Classical scrapie in goats in Cyprus 
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2.  EURL/Cypriot study, Research area 2 
2.1.  Brief overview of the study 
The  objective  of  this  research  area  was  to  study  the  TSE  agent  diversity  and  the 
resistance/susceptibility associated with the D146 and S146 alleles. 
Samples from scrapie affected animals examined between 2005 and 2009 were selected, with the aim 
to  cover  all  geographical  areas  in  Cyprus  where  scrapie  cases  had  been  confirmed,  and  thus 
maximizing the chances to include different TSE strains. Overall, a panel of 400 Cyprus goat isolates 
with matched fixed and fresh brain tissue were subjected to discriminatory immunohistochemistry, 
discriminatory  Western  blot  and  genotyping.  Following  scrutiny  of  the  initial  results,  a  panel  of 
samples was chosen for further examination by discriminatory ELISA and a small subset of samples 
was ultimately selected for characterisation by mouse bioassay (Tg338 and TgShXI). 
According to the provisional results of the study the vast majority of cases were biochemically and 
histopathologically  identical  and  were  classified  as  Classical  scrapie  cases.  Seven  cases,  which 
differed in some test parameters, are still undergoing bioassay. More details on the provisional results 
of the study can be found in the EURL/Cypriot 5
th report on progress (see Appendix A). 
2.2.  Considerations on the provisional results of the study 
The EURL/Cypriot study applied state of the art biochemical PrP
Sc screening to a large Panel of goat 
TSE isolates and bioassayed seven isolates that displayed apparently divergent phenotypes in ovine 
transgenic mice expressing the VRQ (Tg338) and the ARQ (TgShXI) PrP allele. A second passage of 
the seven selected scrapie isolates in Tg338 and TgShXI would allow a comparison of these isolates 
with a representative panel of goat isolates from continental Europe that are being characterised, using 
the same approach, under the framework of the European goatBSE and the EMIDAgoat TSE free 
projects
7. 
Whereas limitations in the current methodology to study  TSE agents diversity preclude concluding 
that  the  EURL study  describe s  the  whole  diversity  of TSE  agents  circulating  in  Cyprus,  this 
experiment identified several phenotypically different strains. Like in the rest of Europe, this diversity 
might represent a limitation to the eradication of Classical scrapie through breeding for resistance and 
to the final interpretation of the experimental inoculations. 
As previously indicated (EFSA, 2009), in vitro conversion assay could be considered as an approach 
to solve this issue. This methodology could investigate the ability of TSE agents to convert PrP
C in 
PrP
Sc within goat PrP substrates of different genotypes. For the purpose of this study, it would allow 
estimating  the  potential  level  of  resistance  associated  to  the  D146  and  S146  alleles  against  the 
different TSE agents proved to be circulating in Cyprus. 
3.  EURL/Cypriot study, Research area 3 
3.1.  Brief overview of the study 
The study aimed at describing PrP
Sc accumulation patterns in CNS and lymphoreticular system of 
healthy and scrapie infected wild type (N146N) and heterozygous or homozygous S146 and D146 
allele carriers from infected herds in Cyprus. 
A total of 1,075 goats aged from 1.1 to 11.2 years (average 3.9 years) originating from 4 herds were 
culled and tested in the last quarter of 2009. Brain, thoracic spinal cord, distal ileum and lateral 
retropharyngeal lymph nodes were tested using immunohistochemistry and ELISA. 
                                                       
7  See www.goatbse.eu and www.emida-era.net Genetic resistance to Classical scrapie in goats in Cyprus 
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As for the other surveys, in the four herds the N146N genotype was the most frequent one (78.9%) 
followed by N146S (11.4%) and N146D (9.0%). Very few animals bearing the other genotypes were 
identified  (3  S146D,  3  D146D  and  1  S146S  goats).  All  234  positive  cases  were  of  the  N146N 
genotype, except one, which was of an unknown genotype. More details on the provisional results of 
the study can be found in the EURL/Cypriot 5
th report on progress (see Appendix A). 
3.2.  Considerations on the provisional results of the study 
Due to the low frequency of S146 and D146 allele carriers in the goat population, the design of the 
protocol allowed to study only a very limited number of homozygous S146 (1 goat) and D146 (3 
goats) allele carriers. None of the S146 and D146 allele carriers appeared to be infected. Therefore no 
information  is  available  on  the  accumulation  of  PrP
Sc  in  lymphoid  tissue  of  goats  carrying  these 
alleles. Nevertheless, the study provided further evidence on the lower susceptibility of heterozygous 
N146S and N146D goats compared to N146N goats. 
The study also documents the occurrence of CNS-positive infected goats in which no deposition of 
PrP
Sc in lymphoid tissue was observed, in line with findings reported in a previous study carried out in 
the UK (Gonzalez et al., 2010; Gonzalez et al., 2009). As indicated above, these results may (or may 
not) limit the significance of the absence of PrP
Sc in the lymphoreticular system of S146 and D146 
allele carriers orally challenged with Classical scrapie for predicting the level of resistance associated 
to these alleles. 
4.  EURL/Cypriot study, Research area 4 
4.1.  Brief overview of the study 
A stochastic model was developed to predict the evolution of the frequency of genotypes in male and 
female Cypriot goats under five different scenarios. Differences between the scenarios included the 
extent of routine genotyping in the population (genotyping of males only vs genotyping of both males 
and females), the genotypes of males accepted for use as sires, and the breeding technique employed 
(natural mating vs artificial insemination). 
In all scenarios, the model predicted a rapid increase of the frequency of the desired alleles in the 
population,  with  almost  a  disappearance  of  the  N146  allele  from  the  male  population  and  of 
homozygous  N146N  male  and  female  goats  within  10  breeding  cycles.  According  to  the  model, 
natural mating would be more efficient than artificial insemination, as a consequence of a much lower 
fertility rate in artificially inseminated goats. 
More details on the provisional results of the study can be found in the EURL/Cypriot 5
th report on 
progress (see Appendix A).  
4.2.  Considerations on the provisional results of the study 
The  genotyping  of  the  entire  Cypriot  goat  population  (see  Chapter  1.1)  clearly  indicated  a  low 
frequency  of  non-N146  carriers.  This  implies  that  the  removal  of  N146  allele  carriers  from  the 
population will require a considerable period of time. 
Some of the assumptions of the model may limit the pertinence of its outputs as compared to the real 
situation:  
  The  herd  structure  of  the  population  was  not  taken  into  account.  The  whole  population  was 
considered  as  a  single  flock,  without  accounting  for  the  sanitary  implications  of  animals’ 
movements. For example, movement restrictions based on the scrapie herd status could have a 
considerable impact on the availability of animals carrying favourable genotypes. Genetic resistance to Classical scrapie in goats in Cyprus 
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  Control of genetic diversity or selection for other health and production traits were not considered. 
This may be a crucial point because the frequencies of non-N146 carriers (S146S, S146D, D146D) 
are presently very low, suggesting that non-N146 carriers could be closely related. 
  No complementary use of artificial insemination with natural mating was modelled, a situation 
normally  encountered  in  real  conditions.  Accounting  for  such  a  possibility  may  change  the 
outcome of the scenarios and their ranking, and may limit the sanitary problems potentially caused 
by animals’ movements. 
It must be also emphasized that the scenarios foreseeing selection of females are based on huge efforts 
in terms of genotyping over many years. 
 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Answer to Term of Reference 1 
Are the provisional results of the study supportive of a lower susceptibility to Classical scrapie in 
goats carrying the D146 and S146 alleles? 
  The provisional results obtained in the study further support the lower susceptibility to Classical 
scrapie in goats carrying the D146 and S146 alleles compared to wild type (N146N) goats. 
  The results from intracerebral challenge are not compatible with a level of resistance as high as the 
one observed in sheep carrying the ARR allele or in goats carrying the K222 allele. 
  Final  results  from  the  oral  challenge  will  be  crucial  in  determining  the  level  of  resistance 
associated with the D146 and S146 alleles. 
Answer to Term of Reference 2 
Are  the  provisional  results  of  the  study  consistent  with  the  possibility  to  use  this  PRNP 
polymorphism in the future to build a genetic strategy to control and eradicate Classical scrapie in 
goats in Cyprus? 
  The provisional results obtained in the study are compatible with the possibility to use the D146 
and S146 alleles to build a genetic strategy to control and eradicate Classical scrapie in goats in 
Cyprus. 
  However: 
o  The success of such a strategy will be determined by the level of resistance associated with the 
D146  and  S146  alleles  against  infection  with  all  the  different  TSE  agents  proved  to  be 
circulating  in  Cyprus,  which  at  this  stage  of  the  EURL/Cypriot  study  remains  to  be 
definitively assessed. 
o  As  compared  to  the  results  of  the  model  developed  in  the  study,  the  efficiency  of  the 
implementation in the field of a breeding strategy selecting for the D146 and S146 alleles may 
be lower due to potential practical constraints related to the management of genetic diversity, 
to the selection for production and health traits and to the need of moving animals for breeding 
purposes in Cyprus. Genetic resistance to Classical scrapie in goats in Cyprus 
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RECOMMENDATIONS 
  A second passage of the seven selected scrapie isolates in Tg338 and TgShXI would allow a 
comparison  of these isolates  with  a  representative  panel  of  goat  isolates from  continental 
Europe that are being characterised using the same approach.  
  In vitro conversion assay could be considered as an approach to estimate the potential level of 
resistance associated to the D146 and S146 alleles against the different TSE agents proved to 
be circulating in Cyprus. 
  The genetic diversity in D146 and S146 allele carriers should be assessed in order to allow the 
estimation of possible side effects of the selection in the Cypriot goat population, such as 
excessive inbreeding. 
  Inclusion in the model of variables like herd structure, preservation of genetic diversity in the 
population,  combined  use  of  artificial  insemination  and  natural  mating,  and  sanitary 
constraints linked to movements of animals should be considered. 
  The  introgression  of  the  K222  allele  into  the  Cypriot  goat  Damascus  breed  could  be 
considered as a possible alternative to selection for the D146 and S146 alleles in case this 
solution was not suitable. The use of genetic molecular markers would allow this process to be 
completed in about four years. 
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TSE resistance in goats in Cyprus - Protocol for additional 
data collection including experimental challenging studies 
 
5
th Report on progress, May 2012.  
 
 
Executive Summary 
 
The aim of this project is to provide further data on the genetic resistance to scrapie in goats 
carrying certain polymorphisms (particularly at codon 146) in the prion protein (PrP) gene with 
the ultimate aim of using this information to control scrapie in goats in Cyprus, and possibly 
beyond, similar to the well-established control of scrapie in sheep through genetic selection 
and controlled breeding (relative to codon 171 in the sheep gene). The experiments are being 
performed by the Veterinary Services in Cyprus and by the TSE EU Reference Laboratory 
(EURL) at AHVLA in the UK. This report summarises the progress made to date in the 
various parts of the project. Details of all data are given in the Annexes.  
 
Central to the project are two inoculation studies in goats of various codon 146 PrP genotypes 
(Part 1a). The intracerebral (ic) inoculations started in spring 2010 and animals of the 
susceptible genotype (NN) succumbed to scrapie in summer 2011. Animals of the other, 
putatively resistant genotypes (ND, NS, SS and DD) also developed clinical disease or 
showed deposition of PrP
Sc in the brain when culled. The ic experiment is now complete, 
although some examinations are still outstanding. A prominent outcome based on the current 
examinations is that animals of the NN-genotype showed widespread PrP
Sc in the CNS and 
the lymphoid tissue, while animals with all other examined genotypes showed PrP
Sc only in 
the CNS. 
 
The oral inoculations of goats of the various genotypes also started during 2010. Clinical 
scrapie has developed in some of the animals of the susceptible genotype (NN), but none of 
the animals of the putatively resistant genotypes (ND, NS, SS and DD) have developed any 
indication of successful infection with scrapie so far. Two timed culls of a subset of animals (6 
and 12 months post inoculation) have been completed and the examinations showed some 
deposition of PrP
Sc in the lymphoid tissue of the susceptible NN-genotype animals only. A 
third cull took place 24 months post inoculation in March 2012  and only animals of the NN-
genotype showed deposition of PrP
Sc in the CNS and the lymphoid tissue, while animals with 
all other examined genotypes were completely negative. 
 
Two additional lines of study are investigating the susceptibility of goats of various genotypes 
in the field situation. The ‘whole-herd cull’ (part 3a) has been finalised, including the diagnosis 
from lymphoid tissue of the culled animals, and it confirms and strengthens the findings from 
earlier case-control studies. Four scrapie-affected herds were culled and a total of 1075 goats 
were genotyped and tested. All positive cases of known genotypes (233) were of the 
susceptible genotype (NN). The analysis showed that the odds of having the NN genotype 
among scrapie cases was over 100 times higher than having any other or unknown genotype 
at codon 146, adjusted by herd and age. The ‘management cull’ (part 1b), while not finalised, 
strongly points in the same direction. So far 422 animals, from 37 herds which have lived 
throughout their productive lives in a scrapie-infected environment, have been culled and 
tested and all the scrapie positive animals identified (n=109) were of the susceptible NN-
genotype. 
 
Another component of this study (part 2a) examined the diversity of the TSE agent in 400 
caprine scrapie cases sampled over 5 years and from many different locations in Cyprus. The 
vast majority of cases were biochemically and histopathologically identical and 
indistinguishable from classical scrapie. A small subset of cases (n = 7), which differed in one 
or more criteria, are currently undergoing bioassay in transgenic mice for a more in depth 
characterization. Preliminary results indicate that two of those isolates differ from the 
prevalent Cypriot caprine scrapie strain, based on biological phenotype. 
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The final investigation developed and employed a mathematical model in an attempt to 
simulate several possible scenarios for a breeding program to reduce the number of fully 
susceptible NN genotype goats in the Cypriot national goat herd (part 4). The results of the 
model showed that the most effective program is to genotype all offspring at a young age and 
use this information to select only the most resistant animals as replacements in a natural 
breeding programme. Assisted reproduction did not offer a significant advantage with regard 
to the rate of allele dissemination. 
 
 
 
 
Protocol 
 
 
Overall Aim of the Study 
 
To provide a protocol for additional data collection based on the EFSA opinion on ‘Genetic 
TSE Resistance in Goats’ to progress knowledge about resistance to scrapie in goats in 
Cyprus. 
 
The protocol represents the final approaches proposed following the discussion between 
representatives of the Commission, the Cypriot Veterinary Services, the CRL (now EURL) 
and EFSA in Brussels on 15
th September 2009.  
 
This report details the progress made to date, and indicates the timeline necessary for 
completion of these studies.  
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Objective 1. Effect of H154, D146 and S146 PRNP alleles on individual 
susceptibility to classical scrapie infection. 
 
 
Background 
 
Two types of experiments were undertaken: 
 
1a) Oral and intracerebral challenge of goats homozygous and heterozygous for the 
alleles of interest 
 
Experimental challenges (intracerebral and oral) are the most rigorous tests for the absolute 
susceptibility of an animal to TSE. While the intracerebral challenge is the most effective and 
rapid mode of infection, the oral challenge most likely mimics the natural mode of infection. 
Goats carrying susceptible and possibly resistant genotypes were challenged with an 
inoculum prepared from a pool of scrapie-affected brains from Cypriot goats. By determining 
the survival times, degree of neuroinvasion and peripheral pathogenesis patterns of TSE 
infection in these genotypes it will be possible to assess the potential value of strategies for 
breeding for resistance in this population. Data from this study will complement the data 
collected from the screening of animals from the whole herd cull (see objective 3a) and 
management cull (Objective 1b), which represent animals with natural field exposure, as 
proposed below.  
 
1b) Production of animals harbouring the genotypes of interest in a number of affected 
herds and follow up evaluation of these goats. 
 
The production of animals harbouring the genotypes of interest is in all likelihood unnecessary 
as in most affected herds there are already a considerable number of animals present with 
these genotypes. The PRNP genotypes of all goats in Cyprus will be determined in a parallel 
study. 
While following up animals with resistant genotypes over several years was not be possible 
within this study, it was hypothesised that some estimate of true resistance (i.e. absence of 
PrP
Sc as opposed to absence of clinical disease) to scrapie could be obtained from the 
screening of selected animals (the ‘management cull’). The animals examined will be adult 
animals with homozygous and heterozygous resistant alleles, at least 6 years old, culled for 
management purposes from herds with confirmed cases of scrapie for at least the lifetime of 
the selected animals for testing, i.e., 6 years. This will ensure that culled animals have been 
exposed to scrapie throughout their lifetime.  A number of animals with susceptible alleles, 
matched by age and herd, will be selected as controls and equally sampled and tested.  
 
 
Results 
 
a) Oral and intracerebral challenge of goats homozygous and 
heterozygous for the alleles of interest 
 
The programme of work and the results can be divided into three phases. 
 
Phase 1:  Sourcing animals, facilities and challenge inocula 
 
Goats of the relevant PrP genotypes were sourced in order that sufficient numbers of kids of 
appropriate age were available for the planned challenges. Kids were identified by ruminal 
bolus at around 2 months of age (dependent on the physical size of the kid), and genotyped.  
There are no sources of goats in Cyprus which could definitely be considered to be scrapie 
free. However, there are government herds, and some commercial herds, in which there have 
been no recorded cases of scrapie recently, and animals to be challenged were purchased 
from these herds.   
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For intra-cerebral challenge, animals up to the age of 15 months were used. For oral 
challenge, the influence of age on susceptibility to scrapie in sheep has been inversely 
correlated with the regression of gut lymphoid tissue and therefore younger animals (3-6 
months of age) were used whenever possible. However, thirty two animals were older (7-12 
months of age) as not enough animals of the right genotype and age were available. 
 
Tables 1 and 2 summarise the requirements for goats and infected material for challenge.  
Thirty-seven goats were required for the intra-cerebral (ic) experiments (table 1 for summary 
Annexe A1 for individual animal details). For homozygous and heterozygous resistant groups, 
8 animals were challenged, with 5 in the non-resistant positive control group. This 
experimental design allows for the culling of 3 animals from each non-NN challenge group at 
the point when the positive control (NN) group develop disease. All other animals were 
allowed to progress to clinical end-point, should it occur.  
For the oral challenge experiment 125 goats were used (table 2 for summary, Annexe B1 for 
individual animal details). Groups of 5 inoculated animals were killed 6 months, 12 months and 
24 months after exposure. A last group of animals will be observed until clinical signs are 
observed or the animals have to be culled for welfare reasons.  
Table 1 
 
Intracerebral: 1ml of 10% brain homogenate in saline 
Recipient genotype  Number of goats  
D146D 8 
S146S 8 
S146N 8 
D146N 8 
N146N 5 
 
 
Table 2 
 
Oral : 5g brain homogenate 
Recipient genotype  Survival time 
 180 
dpi  
360 
dpi 
720 dpi  Clinical 
End-point 
D146D  5*  5 5 5 
S146S  5  5 5 5 
S146N  5  5 5 5 
D146N  5  5 5 5 
N146N  5  5 5 5 
* 5 extra animals of each genotype (i.e. and additional 25 animals) were challenged to help 
maintain group sizes in the event of intercurrent disease problems.  
 
For the ic and oral challenges approximately 1000g of brain tissue from field cases of scrapie 
in Cyprus were used to prepare the inoculum.
  Brains from 12 positive goats (genotype 
N146N; all recipient and donor animals in the inoculation experiments were homozygous R at 
codon 154) were collected to make the inoculum, and sent to the EURL. All the brains were 
Western blotted, and BSE was excluded. There was some bacterial contamination, so the 
inoculum intended for ic challenges was treated and re-tested before being sent back to 
Cyprus in time for the inoculations.  The inoculum used for these challenges has also been 
inoculated into Tg338 and tgShpXI mice (see Annexe D7 for full details). This inoculum is 
considered representative of classical scrapie in Cypriot goats, and will be used as the 
comparator for ‘unusual’ cases identified within objective 2, which have also been put into 
bioassay.  
 
The goats are being maintained for the duration of the experiments in isolation (i.e. fenced in 
such a way that no direct animal to animal contact is possible between challenged and 
unchallenged animals, and with segregation of equipment and staff).  Buildings at the 
Government farm at Athalassa have been refurbished by the Cypriot authorities in order to 
accommodate the animals for this challenge study.  
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Phase 2:  TSE challenge in goats by intracerebral inoculations  
 
In the week from 17-21 May 2010, two staff-members from the EURL, experienced in 
intracerebral inoculation techniques visited Cyprus in order to carry out the intracerebral 
inoculations. As laid down in table 1, a total of 38 goats were successfully challenged. All 
goats were between 12 and 18 months of age and they were inoculated intracerebrally with 
1ml of a 10% brain homogenate from the prepared brain pool (see phase 1).  
 
The development of clinical signs was assessed daily by a veterinary officer. A staff member 
from the EURL, experienced in the clinical assessment process visited Cyprus in Spring 2011 
in order teach the veterinary officer in charge the clinical assessment process. As soon as the 
animals reached an endpoint based on clinical disease, as defined based on observations in 
naturally-occurring field cases, and taking account of ethical requirements, they were killed. 
Nervous system, lymphoid tissue, muscle and various other tissues were sampled aseptically. 
PrP
Sc distribution and amounts in those tissues sampled were established using ELISA and 
IHC.  
The individual animal details and test results for these ic challenged animals is shown in the 
spreadsheet in Annexe A1.  
 
Two animals of the ND group died three months post inoculation from intercurrent diseases 
and a restricted number of tissues were sampled (obex, medial retropharyngeal lymph node 
and mesenteric lymph node). All samples were tested by IHC and were found negative. Two 
further goats (one SS and one DD) died in November 2010, due to intercurrent diseases. 
Both of them were sampled and tested by IHC and ELISA (TeSeE Biorad rapid test), with 
negative results. 
 
In May 2011, approximately 12 months post inoculation, the first clinical signs were seen in 
the NN animals. During June /July 2011 all ND animals developed severe clinical signs and in 
the meantime some of the DD, NS and SS animals were also affected but with moderate 
clinical signs. Animals that reached clinical endpoint were culled and tissues were examined. 
By August 2011 there were no animals alive in the NN (mean incubation period 427d) and the 
ND group (mean ip 425d) and by mid of November 2011 no animals of the DD group were 
alive (mean ip 489d). By April 2012, there were no animals alive of the NS (mean ip 564d) 
and SS group (mean ip 556d). 
 
The results of the biochemical and histological examinations are complex and the 
examinations and their interpretation are far from finalised. However, a few general 
statements can be made: 
 
•  Immunohistochemistry detected PrP
Sc in the brains of all the culled animals 
irrespective of genotype. The pattern of the IHC labeling was similar in all animals 
regardless of the genotype, although intra neuronal and intra glial labeling was more 
prominent in the non-NN animals, and neuropil labeling was much more widespread 
and intense in the NN group (see Annexe A2)  
•  Immunohistochemistry detected PrP
Sc in lymphoid tissue only in animals of the NN-
genotype. 
•  The amounts of PrP
Sc detected in the obex by IHC and rapid test do not necessarily 
correlate with each other. While in NN and ND animals the amounts of PrP
Sc detected 
by IHC were similar, the results from the rapid tests digressed enormously. NN-
animals were strongly positive in the rapid test, while ND-animals were either only 
weakly positive or negative. Further discrepancies between IHC and rapid tests were 
found in the DD, which were clearly positive in the IHC examinations but negative in 
rapid tests. 
•  Western immunoblotting is still underway. Analysis and interpretation will be carried 
out when all cases are completed. 
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In conclusion, it currently seems that animals of all examined genotypes can develop scrapie-
like clinical signs following intracerebral inoculation and that animals of all genotypes have 
detectable amounts of PrP
Sc in the CNS, with the S allele appearing to slightly prolong the 
incubation period.  The most notable difference between the genotypes is that only animals of 
the NN-genotype have shown PrP
Sc in lymphoid tissue. The biochemistry of the accumulated 
PrP may also be different (eg more PK sensitive), since it is not detected in IHC using MAb 
P4. This may also account to some extent for the very low ELISA readings in the positive 
animals of non-NN genotype. This hypothesis is still to be tested by a PK digestion study 
which is being planned at the moment. 
 
 
Phase 3:   Scrapie dynamics in orally exposed goats.  
 
On 9
th and 10
th March 2010 a member of the EURL staff experienced in oral inoculation 
techniques visited Cyprus in order to perform the oral challenges on the animals available by 
that time, together with the staff of the Veterinary Services. All animals (weaned goat kids, 
approximately 3-6 months old) were challenged orally by the administration of 5g of brain 
homogenate into the oropharynx. In total, 85 goats of different genotypes were inoculated and 
Cypriot staff were trained in the inoculation methods. The full panel of oral challenges was 
completed in August 2010. A number of animals died a few days after the inoculation and 
they have been replaced by new animals which were challenged in the first week of January 
2011.  
 
Six months after the oral challenge, 25 animals (5 from each genotype group) were culled and 
sampled  (central nervous system, gut associated lymphoid tissue, secondary lymphoid 
organs, muscle and blood). All samples were tested by IHC. The brainstems of all 25 animals 
were also tested by the TeSeE Biorad rapid test ELISA. Only one NN animal, 9 months old, 
was found positive by IHC, in palatine tonsil and medial retropharyngeal lymph node. 
 
In the 12 month post-inoculation cull, 4/5 NN animals were identified as positive in the 
lymphoreticular system, with evidence of neuroinvasion (brainstem) in one of the four, 
identified by both ELISA and immunohistochemistry. The other 21 animals were negative in 
all examined tissues (a summary of all orally challenged animals culled to date including the 
results of the examinations of the various tissues is given in Annexe B1).Due to intercurrent 
diseases three further animals with the genotypes SS, NN and DD were culled and sampled 8, 
12 and 16 months, post oral inoculation, respectively. All animals were negative. 
 
In February 2012 (23 months post inoculation) two animals, one NN and one NS, that died 
were examined. The NN animal was positive in CNS and lymphoid tissue, while the NS was 
negative.  
 
The 24 month post inoculation cull was performed in March 2012. During this cull 17 animals, 
5 of each of the genotypes, NS, ND, 3 of NN and 4 of DD genotypes, were culled and 
sampled. For the remaining 8 animals (5 SS, 2 NN and 1 DD) the 24 month post inoculation 
cull will be in August 2012 due to the later inoculation dates for these animals, 
 
The results of the biochemical and histological examinations shown PrP
Sc deposition both in 
CNS and lymphoid tissue only in animals with the susceptible NN-genotype. Four of these 
animals were showing clinical signs at this time, which gives a mean incubation time for oral 
challenge in NN as 725d, more than 50% longer than the incubation time in the ic challenged 
animals of the same genotype. The animals with all other examined genotypes were all 
negative. 
 
By May 2012 51 animals are still alive in the experimental Government farm of Athalassa : 9 
NN, 9 ND, 8 NS, 10 DD and 15 SS. 
 
All individual animal status and test results are given in the spreadsheet in Annexe B1.  
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The pattern of the IHC labeling in the oral challenge animals resembles that seen in natural 
infection, withintra-neuronal, intra-glial, punctuate, coalescing or granular and particulate 
immunolabelling in the neuropil or around neuronal perikarya (see Annexe B2).     
 
 
1b) Production of animals harbouring the genotypes of interest in a 
number of affected herds and follow up evaluation of these goats. 
 
The programme of work and the results can be divided into two phases. 
 
 
Phase 1: Genotyping of the entire Cypriot goat population 
 
The PrP genotyping of the entire Cypriot goat population is co-financed by DG-SANCO in the 
framework of the national programme of eradication and monitoring of TSE. As its results 
were valuable and necessary for various parts of this project, the results of the 
comprehensive genotyping are included here.  
 
During the period of September 2010, and until mid of May 2012 about 318,000 goats were 
genotyped in three laboratories abroad. The PrP genotyping results are as follows (codons 
146 and 154 were determined; the genotypes are given e.g. as NR/NR in case of 
homozygosity at both codons 146 (N/N) and 154 (R/R)): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase 2: The ‘management cull’ 
 
For the ‘management cull’ an initial list of approximately 50 herds fulfilling the requirement 
criteria was pre-selected. As per initiative of the Cypriot Veterinary Services, herd owners 
were contacted and after obtaining their consent, the adult animals selected for management 
cull, towards a planned total of 2000, were sampled for determination of their genotype at 
codon 146. The ‘management cull’ screening has not taken place according to the original 
timescale. Following genotyping and selection of animals, many owners opted to keep these 
animals for further breeding to capitalise on their possible lower risk status as indicated by the 
genotype data. 
 
Since August 2009, samples from 423 goats (obex and retropharyngeal lymph node) from 
animals of different ages and genotypes have been collected from 37 scrapie infected herds 
Table 4: PrP genotyping results for the national Cypriot goat herd 
PrP genotype   
2010 – 2012 (until mid May) 
No of animals  Percentage 
(%) 
NR/NR 207,119  65,12 
DR/DR 4,053  1,28 
SR/SR 3,776  1,19 
DR/SR 4,432  1,40 
NR/SR 34,628  10,88 
NR/DR 37,073  11,65 
OTHER  
(NR/NH, NH/NH, 
DR/DH, DR/NH, 
SR/SH and SR/NH) 
26,987 8,48 
TOTAL 318,068  100 
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allocated in four districts (for full details see Annexe C). These samples were tested by IHC 
and 109 of them were found positive. The 109 positive cases were all homozygous NN at 146 
(Table 5). Further testing of samples from 386 of these animals using TeSeE Biorad rapid test 
ELISA identified only 53 of them as positive. 
 
 
 
 
Table 5: The results of animals tested between August 2009 - April 2012 of the “management cull” per 
genotype and age. For breakdown of this data by herd of origin, please refer to Annexe C 
 
 
Age  
(years) 
 
No of animals per genotype  
 
Total  NR/NR NR/SR NR/DR DR/DR SR/SR DR/SR NH/NR  NH/SR 
Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos Neg Pos 
3 1  0  2 0 0 0 0  0  0  0  0 0 1 0 0 0  4 
4 1  1  2 0 1 0 1  0  0  0  1 0 0 0 0 0  7 
5 7  5  1 0 2 0 0  0  0  0  0 0 0 0 0 0 15 
6 21  18  11 0 13 0  1  0  0  0  0 0 5 1 1 0 71 
7 32  26  13 0 15 0  1  0  0  0  0 0  11  2 1 0  101 
8 29  29  19 0 20 0  0  0  0  0  2 0 8 0 0 0  107 
9 22  16  12 0 10 0  0  0  1  0  1 0 5 0 1 0 68 
10 8  7  1 0 6 0 1  0  0  0  0 0 5 0 1 0 29 
11 4  3  3 0 3 0 0  0  0  0  0 0 1 0 0 0 14 
12 2  1  1 0 1 0 0  0  0  0  0 0 0 0 0 0  5 
13 1  0  0 0 1 0 0  0  0  0  0 0 0 0 0 0  2 
TOTAL  128  106  65 0 72 0  4  0  1  0  4 0 6 3 4 0  423 
 
 
 
 
 
 
The management cull is still ongoing, and to date all positive animals have been of the 
susceptible NN genotype. More than 100 animals heterozygous or homozygous for putatively 
resistant alleles have been screened with no positive results. 
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Objective 2. TSE agent diversity and resistance/susceptibility associated 
to H154, D146 and S146 alleles. 
 
Background 
 
2a) characterisation (using biochemistry and bioassay) of a panel of Cypriot TSE 
isolates 
 
While the available data at the time of the design of this project were not suggestive of 
heterogeneity of scrapie strains in Cyprus, they were not able to exclude this possibility. It 
was therefore decided to scrutinize a representative panel of cases using a range of tests. As 
part of routine surveillance procedures, brain samples from scrapie-affected animals were 
examined between 2005 and 2009 by discriminatory Western blot, and BSE was excluded for 
all of them, based on the Western blotting approach detailed in regulation 36/2005. For the 
purpose of this objective, a selection of cases from this population were sourced from 305 
herds and mixed herds and flocks covering all geographical areas in Cyprus where scrapie 
cases had been confirmed and represented approximately half of all infected herds (e.g. 
62.6% of all infected goat herds in 2007 and 42.5% of the all infected herds in 2009). Further 
material from these cases, included fixed brainstem, was subjected to discriminatory IHC, and 
repeat WB. The number of cases and the wide geographical distribution of affected herds 
were intended to maximize the chances of detecting strain diversity. Following scrutiny of the 
initial results, a panel of samples was chosen for further examination by discriminatory ELISA 
(as outlined in the regulation) and a small subset of samples was ultimately selected for 
characterisation by mouse bioassay.  
 
 
Results 
 
A panel of 400 Cypriot goat TSE isolates with matched fixed and fresh tissue were sourced 
retrospectively (approximately 280 cases from 2005 to 2009, see Background above) and 
prospectively. All cases were subjected to discriminatory Western blot (WB), discriminatory 
immunohistochemistry (IHC) and genotyping (to cover codons 143, 146, 151, 154 and 168 of 
the PrP gene). 
 
All examined cases were homozygous NN at codon 146 and the large majority of cases (371) 
showed uniform results in IHC and WB in agreement with classical scrapie in sheep and 
goats and were consistent with the phenotype observed in NN cases from the whole herd cull 
(see part 3.a below). These are considered to be ‘typical’ Cypriot caprine scrapie, and have 
not been investigated further.  
 
Individual test results for the cases selected for further investigation, including the repeat tests, 
are tabulated in Annexe D1, and are summarised below. 
 
Five cases were considered unusual by either WB and/or IHC. They all differ from the 
predominant form of Cypriot scrapie and from each other (see Annexes D2 and D3), therefore 
were selected on this basis to go forward for bioassay (ongoing). They were also subjected to 
further investigation (see below).  
 
Thirteen cases showed some generalised drop off in the level of P4 labelling with IHC (likely 
to be attributable to the technical processing) and five of these were randomly selected for 
further investigation. 
 
An additional group of 11 cases were considered to be scrapie by both WB and IHC but were 
noted to be heterozygous (RH) at codon 151, and five of these were randomly selected for 
further investigation. 
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Two positive cases from the ‘whole herd cull’ (see also part 3.a) that were considered to be 
classical scrapie by both WB and IHC were also included with the panel for further 
investigation, one of which was selected for bioassay (ongoing).  
 
The panel to be investigated further (total 17, plus additional controls) was sent to the CEA 
laboratory in Paris for testing by the discriminatory ELISA (Simon et al
1) and was also 
Western blotted at the EURL using a method to determine if a 14kDa band was present, 
which, if so, distinguishes CH1641-like scrapie from classical and L-type BSE (Baron et al
2).  
 
As the discriminatory ELISA gave some unexpected results with certain control cases 
(Annexe D4), a second panel containing repeat aliquots of anomalous cases plus additional 
controls was sent for testing (Annexe D5). The controls included five samples from 
experimentally transmitted BSE in goats (inoculated intracerebrally with bovine classical BSE 
in the UK). These were also subjected to further WB analysis. 
 
WB images for a representative selection of the uniform samples, together with those 
selected for further investigation are shown in Annexe D2. Details and raw data for the CEA 
discriminatory ELISA testing for the 1
st panel are attached in Annexe D4, and the second 
panel in Annexe D5. WB images and details of WB analysis for the experimental BSE in 
goats are attached in Annexe D6. 
 
 
The results from the further investigation using the CEA-ELISA appear to indicate that 
discrimination between bovine BSE, ovine scrapie and experimental BSE in sheep is clear 
and consistent, but more variability is observed with caprine samples. The WB analysis for 
experimentally transmitted BSE in goats also indicates some samples showing an increase in 
the N-terminal antibody (P4) affinity which is generally considered a characteristic for scrapie.  
The discriminatory tests have been developed and optimised using predominantly ovine 
samples to determine cut off values. The CEA-ELISA had use only of a single French goat 
that was a confirmed as a natural BSE case as a control reference, otherwise caprine BSE 
analysis is limited to the 5 UK experimental goat BSE cases. At this stage we are unable to 
determine whether further optimisation of the test parameters would resolve the apparent 
issues or whether it is a problem inherent with caprine tissues. It is planned to submit this 
data to the next Strain Typing Expert Groups (STEG) meeting for consideration of the impact 
of these observations on the robustness of current discriminatory procedures for small 
ruminant when attempting to characterise caprine isolates.  
 
Further screening of a subset of cases using mass spectroscopy is being considered, but the 
method has not yet been fully optimised for caprine material. 
 
Currently there are six cases that are undergoing bioassay plus one case from the whole herd 
cull (part 3.a), which vary in at least one test parameter (the sample from the whole herd cull 
has given a consistent BSE-like result with the discriminatory CEA-ELISA,) and these assays 
will be compared with the bioassay data generated using the challenge inoculum from 
objective 1 (See Annexe D7). In addition, two of the experimental BSE in goat cases are 
undergoing bioassay (one giving ‘intermediate‘ characteristics by WB and CEA ELISA and the 
other being consistently BSE-like by both tests). All samples were inoculated in the transgenic 
mouse lines tg338 and TgshpXI. Some of the bioassays are still ongoing, but the data 
emerging so far indicates that the isolates form two distinct groups, the majority being similar 
to the inoculum used for the ic and oral challenges. Two of the isolates (PG52/10 and 
PG358/10) differ however from the prevalent Cypriot caprine scrapie strain. 
Immunohistochemical analysis of the mouse tissue is planned, to elucidate which differences 
reflect possible strain differences, rather than possible titre effects.  
 
                                                 
1 Simon et al. (2008) Rapid typing of transmissible spongiform encephalopathy strains with differential 
ELISA. Emerging Infectious Diseases; 14: 608–616. 
 
2 Baron et al (2008) A C-terminal protease-resistant prion fragment distinguishes ovine ‘CH1641-like’ 
scrapie from bovine classical and L-type BSE in ovine transgenic mice. PLoS Pathogens 4;8:e1000137 
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Objective 3. Effect of D146 and S146 PRNP alleles on classical scrapie 
pathogenesis 
  
 
Summary 
The objective of this study was the systematic assessment of PrP
Sc presence in peripheral 
tissue of clinically healthy and scrapie affected animals from infected herds. This was 
achieved by looking at the distribution of PrP
Sc in all animals over 12 month of age from four 
affected herds selected for culling due to their high prevalence of scrapie observed in 
previous years 
 
A total of 1075 goats from the four herds were culled and tested in the last quarter of 2009: 
257, 37, 394 and 387, respectively. The average age of the culled population was 3.9 years, 
with a range from 1.1 to 11.2 years. 
 
Overall in the four herds NN was the most frequent genotype at the 146 codon (78.8%) 
followed by NS (11.3%), DN (9%). The other genotypes were present at a very low frequency: 
DS (0.3%), DD (0.3%) and SS (0.1%). 
 
There were 234 positive cases which correspond to an average herd prevalence of 21.7%. 
The prevalence in each of the four herds was: 28.8%, 56.7%, 20.3% and 15.2%, respectively.  
 
All positive cases were of the NN genotype except one. The only non-NN positive case was of 
unknown genotype and had the following profile: positive to the rapid test and to IHC in both 
obex and LRT  
 
The immunolabelling observed in the positive cases was consistent with that of the prevailing 
field case classical scrapie pathology (data not shown). One case from this cull, initially 
identified erroneously as heterozygous as codon 146, was included in the panel for further 
investigation. This case (PG 52/10) subsequently proceeded to bioassay because of its CEA-
ELISA signature being BSE-like, and is one of two isolates which behave differently to the 
rest in transgenic mice.  
 
 
The odds of having the NN genotype among scrapie cases was over 100 times higher than 
having any other or unknown genotype at codon 146, adjusted by herd and age (95% CI: 16-
866). Positive cases were more likely to occur in goats of, or older than, 27 months than in 
goats younger than 27 months. There were significant differences in the prevalence of scrapie 
between the four herds 
 
When assessing the effect of imperfect test sensitivity by the use of Bayesian model, there 
was no evidence in the data that a significant number of positive animals were missed by the 
imperfect diagnostic tests. In particular, the model estimated a high sensitivity for the IHC test 
at the LRT.  
 
 
The details of this study are given in Annexe E. 
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Objective 4. Capacity for selection and diffusion of the PRNP allele in the 
Cypriot goat population. 
 
Summary  
 
This model attempts to represent several possible scenarios for a breeding program to reduce 
the number of fully susceptible NN genotype goats in the Cypriot national goat herd.  The age, 
breed, sex and genotype structure of the current national goat herd is derived from the results 
of the current national genotyping program and provide baseline data for the model.   
Subsequently the model simulates 10 years of breeding and culling within the herd, applying 
several possible intervention strategies.    
 
The possible interventions involve the genotyping of replacement animals and the use of 
artificial insemination programs. Genotyping replacement animals involves testing males and 
possibly females at an age young enough for the genotype to be considered when selecting 
replacements. The use of artificial insemination provides an opportunity for increasing the 
numbers of female animals that a male can serve in one season. Since there is a lack of data 
on the conception rates associated with such programs, a range of possible values have been 
used. 
 
There are several assumptions in the model that should be considered with the results. With 
replacement animals it is assumed that any offspring can be considered, however it is unlikely 
that all animals will have the desired production traits. The impact of this assumption is that 
there may be an over-estimation in the rate of production of fully resistant animals. 
 
The results of the model show that the most effective program is to genotype all offspring at a 
young age and use this information to select only the most resistant animals as replacements.  
The potential drop in production (number of weaned kids per doe) associated with the use of 
artificial breeding reduces the numbers of offspring to such an extent that it provides little 
advantage over a natural breeding program. Within all the scenarios NN male animals have 
almost disappeared from the population within two generations and fully resistant male 
animals make up the majority of the male population within five or six generations.  For the 
female population the change is slower with most of the NN female animals being eliminated 
from the population within six generations.  The proportions of DD, SS, DS, DN and SN 
animals is largely dependent on the intervention scenario being applied and the use of AI. 
  
The details of this study are given in Annexe F. 
 
 
Interim Conclusions  
 
The oral challenge studies, the management cull and the whole herd cull data all support the 
previously published field observations that on one side the genotype N146N is particularly 
associated with scrapie susceptibility and on the other side the genotypes N146D, N146S, 
D146D, D146S and S146S are associated with a degree of resistance. 
 
All genotypes can succumb to challenge by the intracerebral route, but the resulting 
phenotype is different when comparing the animals carrying genotype N146N with all the 
others (most notably, no detection of PrP
Sc in the periphery of infected animals with all the 
non-N146N-genotypes).   
 
It is important that the oral challenges are continued to endpoint to establish the relative 
resistance of other genotypes to challenge by this more natural route 
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All components of the study reinforce previously published UK caprine data
3  which indicates 
that the current ELISA rapid test screen has considerably lower sensitivity (approx 50%) than 
immunohistochemistry.  
 
The wider issue of discriminatory testing for BSE vs scrapie may need to be reviewed 
(regardless of genotype), since data from these studies suggest that direct extrapolation from 
ovine data may not be appropriate for all caprine isolates. 
 
 
 
 
The TSE European Union Reference Laboratory at the Animal Health and 
Veterinary Laboratory Agency New Haw, UK           
 
The Government Veterinary Services, Cyprus 
 
May 2012 
 
                                                 
3 González et al (2009) High prevalence of scrapie in a dairy goat herd: tissue distribution of disease-
associated PrP and effect of PRNP genotype and age. Vet Res. 40:65 
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